Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Remote brain stimulation and cognitive training to improve thinking after TBI in seniors

Official title: Remote Stimulation and Training to Advance Recovery From TBI in Seniors

Run by Minneapolis Veterans Affairs Medical Center · NCT07332299 · Data updated 2026-11-12

This test will see if combining at-home transcranial direct current stimulation (tDCS) with computer-based cognitive training improves attention, memory, and decision-making in veterans aged 65 and older who had a mild TBI.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment40 (estimated)
SponsorMinneapolis Veterans Affairs Medical Center
Federal
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedJanuary 15, 2026
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedJanuary 12, 2026
Trial IDNCT07332299 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are veterans aged 65 or older with a history of mild TBI at least three months prior, who report attention or concentration difficulties, are on stable medication regimens, and can provide informed consent and participate in remote training.

Probably not a fit

Patients with more severe or unstable medical, psychiatric, or neurological conditions, those unable to complete home-based computer exercises or attend VA visits, non-veterans, or people under 65 are unlikely to match this study's population or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional program assigns older veterans with prior mild TBI to receive either active tDCS during computerized cognitive training or sham tDCS with the same training, delivered at home with remote supervision. Participants complete adaptive BrainHQ exercises targeting attention, working memory, and decision-making while wearing a tDCS device during training sessions. Investigators collect baseline and post-program cognitive and functional assessments to measure changes in thinking and everyday functioning. The study also measures feasibility and acceptability of a home-based, remotely supervised protocol for older adults with TBI.

Why it matters

Potential benefit: If successful, the combined home-based program could improve cognitive abilities and everyday functioning, helping older adults with TBI maintain greater independence.

How similar studies have gone: Previous small studies of tDCS plus cognitive training have shown mixed but sometimes promising short-term cognitive gains, while larger confirmatory trials and fully remote programs remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Veterans age 65 and older.
2. History of mild TBI (as defined by the DOD/VA criteria used in conjunction with the OSU TBI-ID) sustained at least 3 months prior to enrollment.
3. Self-reported or medically documented attention and/or concentration difficulties.
4. Stable dose of all prescription and non-prescription medications that may impact cognition or brain chemistry (except for PRN medication) for at least 3 weeks prior to the baseline session (Visit 1), in the medical opinion of the principal investigator.
5. Capable and willing to provide voluntary informed consent, in the medical opinion of the principal investigator.

Exclusion Criteria:

1. Presence of a medical, psychiatric, physical or non-physical disease, disorder, condition, injury, disability or pre-existent history such that study participation, in the opinion of the principal investigator: (a) may pose a significant risk to the participant, (b) raises the possibility that the participant is unlikely to successfully complete all the requirements of the study according to the study protocol, or (c) might adversely impact the integrity of the data or the validity of the study results. Specific conditions include (but are not limited to) a history of brain tumor near the stimulation site, brain surgery, stroke with current sequalae, epilepsy, multiple sclerosis, Huntington's Disease, ALS, ataxia, aphasia, Alzheimer's Disease, and dementia.
2. Moderate to severe cognitive impairment with MoCA score (assessed upon enrollment) less than 15.
3. Prior treatment with ECT or neuromodulation in the last 12 months.
4. Current severe alcohol or substance use disorder with evidence of withdrawal or tolerance within the past 6 months, based on psychiatric history and/or a review of available medical records.
5. Psychosis or mania within 30 days of enrollment, as determined by the principal investigator, based on psychiatric history and/or a review of available medical records.
6. Contraindications for tDCS (e.g., metallic cranial plates/screws or implanted device, eczema or skin lesions on scalp near electrode site, etc.).
7. No or limited internet connection in their home.

Where it's running

  • Minneapolis VA Health Care System
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.